France: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in France

The French prophylactic medicaments containing insulin market declined slightly to $X in 2022, approximately equating the previous year. The market value increased at an average annual rate of +3.5% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. Over the period under review, the market attained the peak level at $X in 2017; however, from 2018 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in France

In value terms, prophylactic medicaments containing insulin production shrank modestly to $X in 2022 estimated in export price. Over the period under review, production showed a relatively flat trend pattern. The pace of growth was the most pronounced in 2016 with an increase of 15%. As a result, production attained the peak level of $X. From 2017 to 2022, production growth failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from France

In 2022, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were exported from France; surging by 4.8% against 2021. In general, total exports indicated a buoyant increase from 2012 to 2022: its volume increased at an average annual rate of +7.2% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by +69.1% against 2013 indices. The pace of growth was the most pronounced in 2018 with an increase of 20%. Over the period under review, the exports hit record highs in 2022 and are likely to see gradual growth in the near future.

In value terms, prophylactic medicaments containing insulin exports contracted to $X in 2022. Overall, exports saw a relatively flat trend pattern. The pace of growth was the most pronounced in 2018 when exports increased by 32% against the previous year. Over the period under review, the exports hit record highs at $X in 2020; however, from 2021 to 2022, the exports remained at a lower figure.

Exports by Country

Denmark (X tons) was the main destination for prophylactic medicaments containing insulin exports from France, with a 39% share of total exports. Moreover, prophylactic medicaments containing insulin exports to Denmark exceeded the volume sent to the second major destination, Germany (X tons), threefold. The United States (X tons) ranked third in terms of total exports with a 7.4% share.

From 2012 to 2022, the average annual growth rate of volume to Denmark amounted to +33.8%. Exports to the other major destinations recorded the following average annual rates of exports growth: Germany (+0.3% per year) and the United States (+10.3% per year).

In value terms, the United States ($X), Germany ($X) and Denmark ($X) constituted the largest markets for prophylactic medicaments containing insulin exported from France worldwide, together comprising 56% of total exports. Spain, the UK, Italy, China, Canada, Romania, Belgium, Argentina, Turkey and Russia lagged somewhat behind, together comprising a further 25%.

Among the main countries of destination, Romania, with a CAGR of +17.6%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, waning by -18.6% against the previous year. Over the period under review, the export price showed a abrupt contraction. The pace of growth appeared the most rapid in 2018 when the average export price increased by 10% against the previous year. Over the period under review, the average export prices reached the peak figure at $X per ton in 2012; however, from 2013 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices for the major external markets. In 2022, amid the top suppliers, the country with the highest price was the United States ($X per ton), while the average price for exports to Denmark ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the United States (+3.5%), while the prices for the other major destinations experienced mixed trend patterns.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into France

In 2022, after two years of growth, there was significant decline in purchases abroad of medicaments containing insulin but not antibiotics in measured doses, when their volume decreased by -17% to X tons. In general, imports, however, posted strong growth. The most prominent rate of growth was recorded in 2016 when imports increased by 60%. Imports peaked at X tons in 2021, and then reduced sharply in the following year.

In value terms, prophylactic medicaments containing insulin imports fell notably to $X in 2022. Overall, imports, however, posted a strong increase. The pace of growth appeared the most rapid in 2020 with an increase of 147% against the previous year. As a result, imports attained the peak of $X. From 2021 to 2022, the growth of imports remained at a lower figure.

Imports by Country

Denmark (X tons), Italy (X tons) and Germany (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to France, with a combined 90% share of total imports. China, Greece and the United States lagged somewhat behind, together accounting for a further 9.5%.

From 2012 to 2022, the biggest increases were recorded for Greece (with a CAGR of +365.0%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin suppliers to France were Italy ($X), Denmark ($X) and Greece ($X), with a combined 87% share of total imports.

Greece, with a CAGR of +569.7%, saw the highest growth rate of the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, which is down by -42.4% against the previous year. In general, the import price, however, continues to indicate pronounced growth. The pace of growth appeared the most rapid in 2020 when the average import price increased by 99% against the previous year. As a result, import price reached the peak level of $X per ton. From 2021 to 2022, the average import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Greece ($X per ton), while the price for Germany ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Greece (+44.0%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :